John P Phd Longenecker's Net Worth

$1.79 Million

Estimate Recalculated Nov 7, 2024 04:47PM EST

Who is John P Phd Longenecker

John P Phd Longenecker has an estimated net worth of $1.79 Million. This is based on reported shares across multiple companies, which include Pacira Pharmaceuticals, Inc., AILERON THERAPEUTICS INC, and FAVRILLE INC.

SEC CIK

John P Phd Longenecker's CIK is 0001288231

Past Insider Trading and Trends

2013 was John P Phd Longenecker's most active year for acquiring shares with 8 total transactions. John P Phd Longenecker's most active month to acquire stocks was the month of May. 2013 was John P Phd Longenecker's most active year for disposing of shares, totalling 11 transactions. John P Phd Longenecker's most active month to dispose stocks was the month of February. 2015 saw John P Phd Longenecker paying a total of $89,700.00 for 9,000 shares, this is the most they've acquired in one year. In 2022 John P Phd Longenecker cashed out on 14,000 shares for a total of $502,145.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Pacira Pharmaceuticals, Inc.

Investor
Updated Mar 07, 2022
Form 4
-27.11%
-7.00K
$41.28
-$426.47K
Mar 07, 2022
18.82K
Sale
Mar 03
Form 4
48.95%
8.69K
Jun 11, 2021
26.45K
Grant
Jun 09
Form 4
-21.97%
-5.00K
$43.12
-$291.40K
Mar 03, 2021
17.76K
Sale
Mar 01
Form 4
56.30%
9.29K
Jun 11, 2020
25.78K
Grant
Jun 09
Form 4
$1.61
$6.01K
Mar 16, 2020
16.50K
Options
Mar 12
Form 4
-7.30%
-1.30K
$23.87
-$53.53K
Dec 04, 2019
16.50K
Sale
Dec 02
Form 4
212.10%
12.57K
Jun 06, 2019
18.50K
Grant
Jun 05
Form 4
106.41%
5.47K
Jun 15, 2018
10.62K
Grant
Jun 13
Form 4
107.47%
4.07K
Jun 16, 2017
7.86K
Grant
Jun 14
Form 4
194.04%
4.46K
Jun 17, 2016
6.76K
Grant
Jun 15
Form 4
15.00%
300.00
$66.55
$19.96K
Jan 14, 2016
2.30K
Purchase
Jan 12
Form 4
6.00K
Jun 05, 2015
6.00K
Grant
Jun 03
Form 4
-100.00%
-3.00K
$62.59
-$196.14K
Mar 16, 2015
Sale
ScheduledMar 12
Form 4
-25.00%
-1.00K
$61.61
-$63.42K
Dec 30, 2014
3.00K
Sale
ScheduledDec 29
Form 4
-20.00%
-1.00K
$63.15
-$66.50K
Sep 30, 2014
4.00K
Sale
ScheduledSep 29
Form 4
-16.67%
-1.00K
$60.75
-$61.70K
Jul 02, 2014
5.00K
Sale
ScheduledJun 30
Form 4
8.00K
Jun 05, 2014
8.00K
Grant
Jun 03
Form 4
-14.29%
-1.00K
$47.27
-$34.73K
Mar 31, 2014
6.00K
Sale
ScheduledMar 28
Form 4
-24.42%
-2.50K
$28.58
-$134.85K
Jan 02, 2014
7.74K
Sale
ScheduledDec 30
Form 4
-65.02%
-2.50K
$24.18
-$112.82K
Oct 02, 2013
1.35K
Sale
ScheduledSep 30
Form 4
-27.40%
-2.00K
$14.85
-$52.96K
Jul 02, 2013
5.30K
Sale
ScheduledJun 28
Form 4
7.00K
Jun 14, 2013
7.00K
Grant
Jun 12
Form 4
-43.02%
-2.00K
$15.05
-$53.76K
Apr 01, 2013
2.65K
Sale
ScheduledMar 28
Form 4
7.00K
Jun 07, 2012
7.00K
Grant
Jun 05
Form 4
5.00K
Jun 06, 2011
5.00K
Grant
Jun 02
Form 3
Feb 02, 2011
Showing 26 results

AILERON THERAPEUTICS INC

President and CEO
Updated Aug 14, 2018
Form 4
10.00K
$2.45
$24.50K
Aug 14, 2018
10.00K
Purchase
Aug 10
Form 4
30.00K
May 17, 2018
30.00K
Grant
May 15
Form 3
May 17, 2018
Showing 3 results

FAVRILLE INC

President and CEO
Updated Jan 29, 2009
Form 4
2.41M
Jan 29, 2009
2.41M
Grant
Jan 27
Form 4
-100.00%
-172.06K
$0.02
-$4.08K
Dec 15, 2008
Sale
Dec 11 - Dec 12
Form 4
-7.02%
-13.00K
May 08, 2008
172.06K
Grant
May 08
Form 4
271.69K
Mar 12, 2007
271.70K
Grant
Mar 09
Form 4
267.25K
Mar 27, 2006
267.26K
Grant
Mar 23
Form 4
168.44K
Apr 12, 2005
168.45K
Grant
Mar 29
Form 3
Feb 02, 2005
185.06K
Showing 7 results